Cargando…

824 An Open-Label Phase 3 Study of Isavuconazole (VITAL): Focus on Mucormycosis

Detalles Bibliográficos
Autores principales:	Marty, Francisco M., Perfect, John R., Cornely, Oliver A., Mullane, Kathleen M., Rahav, Galia, Lee, Misun, Ito, Masanori, Maher, Rochelle, Zeiher, Bernhardt, Ostrosky-Zeichner, Luis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2014
Materias:	IDWeek 2014 Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5782119/ http://dx.doi.org/10.1093/ofid/ofu052.532

Ejemplares similares

1210 A Phase 3, Randomized, Double-Blind, Non-inferiority Trial to Evaluate Efficacy and Safety of Isavuconazole versus Voriconazole in Patients with Invasive Mold Disease (SECURE): Outcomes in Neutropenic Patients
por: Patterson, Thomas, et al.
Publicado: (2014)

825 A Phase 3, Randomized, Double-Blind, Non-Inferiority Trial to Evaluate Efficacy and Safety of Isavuconazole vs Voriconazole in Patients with Invasive Mold Disease (IMD): Outcomes in Patients with Pulmonary Infections
por: Raad, Issam, et al.
Publicado: (2014)

1211 A Phase 3, Randomized, Double-Blind, Non-Inferiority Trial to Evaluate Efficacy and Safety of Isavuconazole versus Voriconazole in Patients with Invasive Mold Disease (SECURE): Outcomes in Invasive Aspergillosis Patients
por: Kontoyiannis, Dimitrios, et al.
Publicado: (2014)

Isavuconazole treatment for rare fungal diseases and for invasive aspergillosis in patients with renal impairment: Challenges and lessons of the VITAL trial
por: Perfect, John R., et al.
Publicado: (2018)

Isavuconazole Treatment of Cryptococcosis and Dimorphic Mycoses
por: Thompson, George R., et al.
Publicado: (2016)

Isavuconazole: Mechanism of Action, Clinical Efficacy, and Resistance
por: Ellsworth, Misti, et al.
Publicado: (2020)

1467 Delaying Diagnostic Procedure Significantly Increases Mortality in Patients with Invasive Mucormycosis
por: Lee, Ji Un, et al.
Publicado: (2014)

Isavuconazole for the treatment of patients with invasive fungal diseases involving the central nervous system
por: Schwartz, Stefan, et al.
Publicado: (2020)

468 RBX2660 (microbiota suspension) for Recurrent C. difficile Infection: 60-Day Interim Analysis of the PUNCH-CD Phase 2 Safety Study
por: Dubberke, Erik, et al.
Publicado: (2014)

Post-exposure prophylaxis with isavuconazole after occupational exposure to Rhizopus
por: Al-Obaidi, Mohanad, et al.
Publicado: (2018)

Isavuconazole as salvage therapy for mucormycosis
por: Graves, Bianca, et al.
Publicado: (2016)

745 Risk of Peripheral Blood Eosinophilia and Hypersensitivity Reactions among Patients Receiving Outpatient Parenteral Antibiotics
por: Blumenthal, Kimberly, et al.
Publicado: (2014)

313 Value of Discontinuation of Contact Precautions (CP) for Methicillin-Resistant Staphylococcus aureus (MRSA)
por: Shenoy, Erica S., et al.
Publicado: (2014)

Rhinoorbital mucormycosis in the immunocompetent: Experience with Isavuconazole
por: Ilharco, Marta, et al.
Publicado: (2019)

711 Clinical epidemiology of patients with blood stream infection in a nationwide institution of Rheumatology in Japan
por: Hanaoka, Masanori, et al.
Publicado: (2014)

Isavuconazole in the treatment of invasive aspergillosis and mucormycosis infections
por: Donnelley, Monica A, et al.
Publicado: (2016)

252 S-649266, a Novel Siderophore Cephalosporin: In vitro activity against Gram-negative bacteria
por: Tsuji, Masakatsu, et al.
Publicado: (2014)

667 The Timing of Hepatitis B virus Vaccination Does Not Influence Seropositivity Rates of Pediatric Liver Transplantation Recipients
por: Ito, Kenta, et al.
Publicado: (2014)

1075 Effectiveness and Safety of Immunization with Live-attenuated and Inactivated Vaccines for Pediatric Liver Transplantation Recipients
por: Ito, Yoshinori, et al.
Publicado: (2014)

256 S-649266, a Novel Siderophore Cephalosporin: Mechanisms of enhanced activity and beta-lactamase stability
por: Tsuji, Masakatsu, et al.
Publicado: (2014)

801 Molecular Epidemiological Characteristics of Klebsiella pneumoniae Associated with Bacteremia among Patients with Pneumonia
por: Ito, Ryota, et al.
Publicado: (2014)

Isavuconazole: A Promising Salvage Therapy for Invasive Mucormycosis
por: Shafiq, Muhammad, et al.
Publicado: (2018)

Breaking the mold: A case of pulmonary mucormycosis treated with isavuconazole
por: Huggins, Jonathan, et al.
Publicado: (2018)

304 Methicillin-resistant Staphylococcus aureus in Ohio EMS providers: A statewide cross-sectional study
por: Orellana, Robert, et al.
Publicado: (2014)

113 Procedure-specific Surgical Site Infection (SSI) Prevalence Widely Varies within Certain NHSN (National Healthcare Safety Network) Surgery Groups
por: Saeed, Mohammed, et al.
Publicado: (2014)

1124 Clinical characteristics of adult patients with influenza B and A infections during 2013/2014 flu season
por: Ahn, Mi Young, et al.
Publicado: (2014)

1543 Counting the Costs of Falsely Labeling Patients as HIV-Positive in Tahoua Region, Niger
por: Megill, Matthew
Publicado: (2014)

538 A Retrospective Study to Evaluate the Safety of Switching Antiretroviral Therapy (ART) to Rilpivirine/Tenofovir Disoproxil Fumarate/Emtricitabine (RPV/TDF/FTC) STR in Virologically Suppressed HIV-Infected Patients
por: Monczor, Ana, et al.
Publicado: (2014)

1067 Multi-Attribute Ranking Tool for Vaccines: Strategic Priority Setting to Support Vaccine Development
por: Madhavan, Guruprasad, et al.
Publicado: (2014)

1535 Knowledge, Practice, and Attitudes of University of California San Diego Medical Students with Regard to HIV and HIV Screening
por: Katsivas, Theodoros, et al.
Publicado: (2014)

1550 Can We Re-engage Patients with HIV Who Are Lost to Care? A Pilot Study in a Large Urban HIV Clinic
por: Lee, Dong Heun, et al.
Publicado: (2014)

473 Comparison of MicroScan System Prompt and Turbidity Methods for Measuring Vancomycin Minimum inhibitory concentration (MIC) against Methicillin-resistant Staphylococcus aureus (MRSA) with MIC of 2ug/ml, the Clinical Implications and economic impact of using alternative antimicrobial agents to vancomycin for MRSA with possible MIC of 2ug/ml
por: Kamran, Amir, et al.
Publicado: (2014)

870 The Epidemiology of CAUTI due to Candida spp. in the Intensive Care Unit (ICU) - Infection or Colonization?
por: Tashtoush, Nader, et al.
Publicado: (2014)

1454 Antifungal Susceptibility Patterns of a Global Collection of Fungal Isolates and Polysorbate-80 Effect on the Susceptibility of the Antifungal Classes
por: Castanheira, Mariana, et al.
Publicado: (2014)

766 Clinical Features and Outcome of Patients with Middle East Respiratory Syndrome-Coronavirus (MERS-CoV) Infection
por: Alraddadi, Basem, et al.
Publicado: (2014)

1624 Risk Factors for Hospital-Acquired Clostridium difficile
por: Knepper, Bryan, et al.
Publicado: (2014)

1551 The Patient-Centered Medical Home: A Reality for HIV Care in Nigeria
por: Ahonkhai, Aimalohi, et al.
Publicado: (2014)

1663 Imported Exotic Infectious Diseases in Columbia, Missouri
por: Regunath, Hariharan, et al.
Publicado: (2014)

1627 Diagnostic Accuracy of Loop-Mediated Isothermal DNA Amplification (LAMP) Assay for Detection of Clostridium difficile Infection (CDI): a Meta-Analysis
por: Lloyd, Aaron, et al.
Publicado: (2014)

1681 Randomized Clinical Trial of the Recovery of Probiotics Lactobacillus rhamnosus GG (LGG) and Bifidobacterium animalis subspecies lactis (BB-12) from the Gastrointestinal (GI) Tract of Healthy Volunteers
por: Poutsiaka, Debra D., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_jqo3s36s04cen0ktb55vgt72i8